Rocha, S.; Amaro, A.; Ferreira-Junior, M.D.; Proença, C.; Silva, A.M.S.; Costa, V.M.; Oliveira, S.; Fonseca, D.A.; Silva, S.; Corvo, M.L.;
et al. Melanoxetin: A Hydroxylated Flavonoid Attenuates Oxidative Stress and Modulates Insulin Resistance and Glycation Pathways in an Animal Model of Type 2 Diabetes Mellitus. Pharmaceutics 2024, 16, 261.
https://doi.org/10.3390/pharmaceutics16020261
AMA Style
Rocha S, Amaro A, Ferreira-Junior MD, Proença C, Silva AMS, Costa VM, Oliveira S, Fonseca DA, Silva S, Corvo ML,
et al. Melanoxetin: A Hydroxylated Flavonoid Attenuates Oxidative Stress and Modulates Insulin Resistance and Glycation Pathways in an Animal Model of Type 2 Diabetes Mellitus. Pharmaceutics. 2024; 16(2):261.
https://doi.org/10.3390/pharmaceutics16020261
Chicago/Turabian Style
Rocha, Sónia, Andreia Amaro, Marcos D. Ferreira-Junior, Carina Proença, Artur M. S. Silva, Vera M. Costa, Sara Oliveira, Diogo A. Fonseca, Sónia Silva, Maria LuÃsa Corvo,
and et al. 2024. "Melanoxetin: A Hydroxylated Flavonoid Attenuates Oxidative Stress and Modulates Insulin Resistance and Glycation Pathways in an Animal Model of Type 2 Diabetes Mellitus" Pharmaceutics 16, no. 2: 261.
https://doi.org/10.3390/pharmaceutics16020261
APA Style
Rocha, S., Amaro, A., Ferreira-Junior, M. D., Proença, C., Silva, A. M. S., Costa, V. M., Oliveira, S., Fonseca, D. A., Silva, S., Corvo, M. L., Freitas, M., Matafome, P., & Fernandes, E.
(2024). Melanoxetin: A Hydroxylated Flavonoid Attenuates Oxidative Stress and Modulates Insulin Resistance and Glycation Pathways in an Animal Model of Type 2 Diabetes Mellitus. Pharmaceutics, 16(2), 261.
https://doi.org/10.3390/pharmaceutics16020261
